D-0223-2024 Class II
FDA drug recall D-0223-2024 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 2, 2024 and is designated Class II. Reason for recall: Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets. Affected quantity: 38,952 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 17, 2024
- Initiation Date
- Jan 2, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 38,952 bottles
Product Description
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
Reason for Recall
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Distribution Pattern
USA Nationwide
Code Information
Lot #: T2304007, Exp 7/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0223-2024
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026